Correlation Between Vaccinex and CohBar
Can any of the company-specific risk be diversified away by investing in both Vaccinex and CohBar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and CohBar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and CohBar Inc, you can compare the effects of market volatilities on Vaccinex and CohBar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of CohBar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and CohBar.
Diversification Opportunities for Vaccinex and CohBar
Pay attention - limited upside
The 3 months correlation between Vaccinex and CohBar is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and CohBar Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CohBar Inc and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with CohBar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CohBar Inc has no effect on the direction of Vaccinex i.e., Vaccinex and CohBar go up and down completely randomly.
Pair Corralation between Vaccinex and CohBar
If you would invest (100.00) in CohBar Inc on December 29, 2024 and sell it today you would earn a total of 100.00 from holding CohBar Inc or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Vaccinex vs. CohBar Inc
Performance |
Timeline |
Vaccinex |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
CohBar Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Vaccinex and CohBar Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and CohBar
The main advantage of trading using opposite Vaccinex and CohBar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, CohBar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CohBar will offset losses from the drop in CohBar's long position.Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
CohBar vs. Enveric Biosciences | CohBar vs. Elevation Oncology | CohBar vs. Hepion Pharmaceuticals | CohBar vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |